| Model Number |
S606 |
| Medical Device Problem Codes |
Failure to Capture (1081); Pacing Problem (1439); Data Problem (3196)
|
| Health Effect - Clinical Code |
Cardiac Arrest (1762)
|
| Date of Event |
06/07/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that the patient with this pacemaker experienced cardiac arrest.Upon review, it was noted that the device is programmed in aoo mode, an unusual permanent setting, raising concerns about potential lead issues.During programmer testing, 100% rv pacing was observed, likely due to testing conditions, as rv pacing should not occur in aoo mode.In addition, ra loss of capture was suspected.Currently, this product remains in service and no additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.Dimensional analysis of the header was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the pacing and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient with this pacemaker experienced cardiac arrest.Upon review, it was noted that the device is programmed in aoo mode, an unusual permanent setting, raising concerns about potential lead issues.During programmer testing, 100% rv pacing was observed, likely due to testing conditions, as rv pacing should not occur in aoo mode.In addition, ra loss of capture was suspected as a result of the programming.Currently, this product remains in service and no additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|